Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gleevec in Children With Pulmonary Hypertension
NCT00583115Phase 2Terminated
- Sponsor
- Indiana University
- Start
- Oct 2007
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in idiopathic pulmonary arterial hypertension (IPAH), sponsored by Indiana University. Started Oct 2007; status: terminated.
02
Drugs
03
Conditions
idiopathic pulmonary arterial hypertension (IPAH)
Beyond the preview
Go deeper on NCT00583115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00583115.